Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).


TSXV:MPH - Post by User

Comment by Investorwpgon May 30, 2020 8:48am
209 Views
Post# 31091425

RE:RE:RE:RE:Have to think he knows more than Mackie

RE:RE:RE:RE:Have to think he knows more than MackieWhat I find astonishing is that Medicure is still buying back shares!  May 24th and 29th SEDI filings show Medicure has spent roughly $150,000 buying back shares.  Repurchasing and cancellation of shares will continue to increase Bert Friesen's ownership percentage at the expense of the company's going concern.  Medicure continues to burn through its limited cash balance with dwindling revenues.  Why allocate funds to share buybacks if they may need that money to fund its continued operational losses?  Where is the accountability?  I really question the true "independence" of the Board of Directors...
<< Previous
Bullboard Posts
Next >>